Folgen
Malik Juweid
Titel
Zitiert von
Zitiert von
Jahr
Revised response criteria for malignant lymphoma
BD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ...
Journal of clinical oncology 25 (5), 579-586, 2007
54642007
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ...
Journal of clinical oncology 25 (5), 571-578, 2007
17012007
Positron-emission tomography and assessment of cancer therapy
ME Juweid, BD Cheson
New England Journal of Medicine 354 (5), 496-507, 2006
9502006
Epidemiology and outcome of glioblastoma
AF Tamimi, M Juweid
Exon Publications, 143-153, 2017
7452017
Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats
MJ Abrams, M Juweid, DA Schwartz, MM Hauser, FE Gaul, AJ Fuccello, ...
Journal of Nuclear Medicine 31 (12), 2022-2028, 1990
5771990
Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier
M Juweid, R Neumann, C Paik, MJ Perez-Bacete, J Sato, W van Osdol, ...
Cancer research 52 (19), 5144-5153, 1992
5281992
Response assessment of aggressive non-Hodgkin’s lymphoma by integrated International Workshop Criteria and fluorine-18–fluorodeoxyglucose positron emission tomography
ME Juweid, GA Wiseman, JM Vose, JM Ritchie, Y Menda, JE Wooldridge, ...
Journal of Clinical Oncology 23 (21), 4652-4661, 2005
5072005
The role of FDG-PET scans in patients with lymphoma
P Seam, ME Juweid, BD Cheson
Blood, The Journal of the American Society of Hematology 110 (10), 3507-3516, 2007
4042007
AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development
SN Khleif, JH Doroshow, WN Hait
Clinical Cancer Research 16 (13), 3299-3318, 2010
2362010
Molecular imaging of proliferation in malignant lymphoma
AK Buck, M Bommer, S Stilgenbauer, M Juweid, G Glatting, ...
Cancer research 66 (22), 11055-11061, 2006
2182006
Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives
TM Behr, RM Sharkey, ME Juweid, RD Blumenthal, RM Dunn, GL Griffiths, ...
Cancer research 55 (17), 3825-3834, 1995
2111995
Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG
TM Behr, RM Sharkey, ME Juweid, RM Dunn, RC Vagg, Z Ying, ...
Journal of Nuclear Medicine 38 (6), 858-870, 1997
1781997
Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody
M Juweid, RM Sharkey, A Markowitz, T Behr, LC Swayne, R Dunn, ...
Cancer Research 55 (23_Supplement), 5899s-5907s, 1995
1711995
Role of positron emission tomography in lymphoma
ME Juweid, BD Cheson
Journal of Clinical Oncology 23 (21), 4577-4580, 2005
1682005
Radioimmunotherapy of B-cell non-Hodgkin’s lymphoma: from clinical trials to clinical practice
ME Juweid
Journal of Nuclear Medicine 43 (11), 1507-1529, 2002
1572002
Pharmacokinetics, Dosimetry, and Initial Therapeutic Results with 131I- and 111In-90Y-Labeled Humanized LL2 Anti-CD22 Monoclonal Antibody in Patients with …
ME Juweid, E Stadtmauer, G Hajjar, RM Sharkey, S Suleiman, S Luger, ...
Clinical cancer research 5 (10), 3292s-3303s, 1999
1571999
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study
SJ Horning, ME Juweid, H Schöder, G Wiseman, A McMillan, LJ Swinnen, ...
Blood, The Journal of the American Society of Hematology 115 (4), 775-777, 2010
1562010
International Harmonization Project on Lymphoma
BD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ...
Revised response criteria for malignant lymphoma. J Clin Oncol 25 (5), 579-586, 2007
1542007
Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies
RM Sharkey, M Juweid, J Shevitz, T Behr, R Dunn, LC Swayne, GY Wong, ...
Cancer Research 55 (23_Supplement), 5935s-5945s, 1995
1251995
Radioimmunotherapy of non-Hodgkin’s lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
RM Sharkey, A Brenner, J Burton, G Hajjar, SP Toder, A Alavi, A Matthies, ...
Journal of Nuclear Medicine 44 (12), 2000-2018, 2003
1202003
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20